Abizer Gaslightwala
Vermogen: 6 149 $ op 31-05-2025
Vermogen: 6 149 $ op 31-05-2025
Mr. Abizer Gaslightwala is a President, Chief Executive Officer & Director at Akari Therapeutics Plc and a Senior Vice President at Jazz Pharmaceuticals Plc.
He is on the Board of Directors at Akari Therapeutics Plc.
He received his undergraduate degree from Cornell University, a graduate degree from Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-06-2026 | 614.856.000 ( 0,44% ) | 6 149 $ | 31-05-2025 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Algemeen Directeur | 21-04-2025 |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01-10-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau